Article Information
History
- June 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, 97080 Wuerzburg, Germany
- 2Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany
- 3Centre for Evidence Synthesis in Global Health, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK
- 4Cochrane Injuries Group, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK
- ↵*Correspondence to:
PD Dr. Stephanie Weibel, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Oberduerrbacher Str. 6, 97080 Wuerzburg, Germany, Telephone: +49-931-201-30310, E-mail address: weibel_s{at}ukw.de
Posted June 05, 2022.
Identifying and managing problematic trials: a Research Integrity Assessment (RIA) tool for randomized controlled trials in evidence synthesis
